Article Access statistics

Viewed: 27

Emailed: 0

PDF Downloaded: 11

IP Indian Journal of Clinical and Experimental Dermatology


Ocular rosacea: The insight


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Tejinder Kaur*, Anisha Sethi, Niharika Mittal, Karamjit Singh

Volume : 6, Issue : 2, Year : 2020

Article Page : 194-199


Suggest article by email

Abstract

Introduction: Rosacea is a chronic cutaneous disorder with non specific and variable ocular manifestations.
Ocular rosacea is often underdiagnosed, despite the potential for serious sight threatening sequelae.
Aim: The study was designed to determine the incidence of ocular disease among the population of rosacea
patients along with evaluating the presence of eye dryness in both the patients and controls using Schirmer
1 test. It correlated the severity of ocular disease with the severity of cutaneous rosacea.
Materials and Methods: A total of 72 patients with facial rosacea were enrolled and evaluated with
thorough history, physical and ophthalmological examination for ocular rosacea. Schirmer’s test was
performed on all patients with ocular rosacea and controls.
Results: Out of 72 patients with facial rosacea, 30 (41.62%) were diagnosed with ocular rosacea. On
the Schirmer test, ocular rosacea patients had statistically significant lower value than the control group.
There was also a statistically significant difference between mean Schirmer test values of male patients and
controls and female patients and controls.
Conclusion: Symptoms of ocular rosacea are not always specific hence underdiagnosed. Ocular features
of rosacea in patients presenting with mere cutaneous findings should not be overlooked.

Keywords: Ocular, Rosacea, Schirmer’s test.

Doi : 10.18231/j.ijced.2020.039

How to cite : Kaur T , Sethi A, Mittal N, Singh K, Ocular rosacea: The insight. IP Indian J Clin Exp Dermatol 2020;6(2):194-199

Copyright © 2020 by author(s) and IP Indian J Clin Exp Dermatol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)